ASX-Listed Oncology Biotech The CompanyOur client is an innovative ASX-listed biotechnology company based in inner Melbourne, with more than 20 years experience advancing proprietary dendrimer technology from discovery to clinical application. Its mission is to improve outcomes for patients with serious illnesses, particularly cancer, by developing novel dendrimer-based therapies. The company has achieved strong clinical validation across multiple Phase 2 oncology programs and is advancing ...
Insert additional messaging here.
